Filing Details
- Accession Number:
- 0001209191-20-057067
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-11-04 21:34:08
- Reporting Period:
- 2020-11-02
- Accepted Time:
- 2020-11-04 21:34:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1770787 | 10X Genomics Inc. | TXG | Laboratory Analytical Instruments (3826) | 455614458 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1786391 | J. Benjamin Hindson | C/O 10X Genomics, Inc. 6230 Stoneridge Mall Road Pleasanton CA 94588 | See Remarks | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Acquisiton | 2020-11-02 | 21,062 | $0.88 | 88,562 | No | 4 | M | Direct | |
| Class A Common Stock | Disposition | 2020-11-02 | 3,328 | $135.36 | 85,234 | No | 4 | S | Direct | |
| Class A Common Stock | Disposition | 2020-11-02 | 13,242 | $136.11 | 71,992 | No | 4 | S | Direct | |
| Class A Common Stock | Disposition | 2020-11-02 | 1,940 | $136.98 | 70,052 | No | 4 | S | Direct | |
| Class A Common Stock | Disposition | 2020-11-02 | 1,146 | $138.06 | 68,906 | No | 4 | S | Direct | |
| Class A Common Stock | Disposition | 2020-11-02 | 1,406 | $139.13 | 67,500 | No | 4 | S | Direct | |
| Class A Common Stock | Acquisiton | 2020-11-03 | 12,688 | $0.88 | 80,188 | No | 4 | M | Direct | |
| Class A Common Stock | Disposition | 2020-11-03 | 398 | $135.52 | 79,790 | No | 4 | S | Direct | |
| Class A Common Stock | Disposition | 2020-11-03 | 4,642 | $136.62 | 75,148 | No | 4 | S | Direct | |
| Class A Common Stock | Disposition | 2020-11-03 | 7,353 | $137.57 | 67,795 | No | 4 | S | Direct | |
| Class A Common Stock | Disposition | 2020-11-03 | 295 | $138.49 | 67,500 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Class A Common Stock | Stock Option (right to buy) | Disposition | 2020-11-02 | 21,062 | $0.00 | 21,062 | $0.88 |
| Class A Common Stock | Stock Option (right to buy) | Disposition | 2020-11-03 | 12,688 | $0.00 | 12,688 | $0.88 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 91,438 | 2025-10-27 | No | 4 | M | Direct | |
| 78,750 | 2025-10-27 | No | 4 | M | Direct |
Footnotes
- The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person.
- This transaction was executed in multiple trades at prices ranging from $134.74 to $135.73. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- This transaction was executed in multiple trades at prices ranging from $135.75 to $136.71. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- This transaction was executed in multiple trades at prices ranging from $136.77 to $137.40. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- This transaction was executed in multiple trades at prices ranging from $137.77 to $138.40. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- This transaction was executed in multiple trades at prices ranging from $138.77 to $139.67. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- This transaction was executed in multiple trades at prices ranging from $135.07 to $135.98. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- This transaction was executed in multiple trades at prices ranging from $136.09 to $137.07. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- This transaction was executed in multiple trades at prices ranging from $137.11 to $138.08. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- This transaction was executed in multiple trades at prices ranging from $138.20 to $138.66. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- All of the shares subject to the option are fully vested and exercisable as of the date hereof.
Billionaire Hedge Funds
